Relapse Rate After Glucocorticoid‐Free Remission in Patients With Idiopathic Inflammatory Myopathies and Validation of the International Myositis Assessment and Clinical Studies Group Criteria for Complete Clinical Response and Worsening
Relapses were frequent in patients with IIM after achieving glucocorticoid-free remission and required management of therapy. IMACS criteria for complete clinical response/worsening need to be amended.
Authors
- Ingrid E. Lundberg (ORCID: https://orcid.org/0000-0002-6068-9212)
- Karin Lodin (ORCID: https://orcid.org/0000-0002-3789-199X)
- Hideaki Tsuji (ORCID: https://orcid.org/0000-0002-2521-246X)
- Maryam Dastmalchi
- Irene Peralta Garcia
- Fabricio Espinosa‐Ortega (ORCID: https://orcid.org/0000-0001-6227-8209)
Institutions
- Karolinska University Hospital (SE)
- Kyoto University (JP)
- Karolinska Institutet (SE)
Publication Details
- Journal
- Arthritis & Rheumatology
- Published
- 2025-11-10
- DOI
- https://doi.org/10.1002/art.43429
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- Nakatomi Foundation
- Boehringer Ingelheim Japan
- Argenx
- Karolinska Institutet
- Vetenskapsrådet
- Svenska Läkaresällskapet
- Reumatikerförbundet
- EMD Serono
- Chugai Pharmaceutical
- Japan Society for the Promotion of Science
- Daiichi Sankyo Europe